Corporate Compliance

Drug, device ties capped at $50K for docs on FDA ad boards

Compliance Monitor, April 4, 2007

Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

The FDA has proposed stricter conflict of interest rules that set a grant or fee cap of $50,000 for experts who serve on the FDA's advisory committees. Outsides experts with more than $50,000 in ties to drug and device companies regulated by the FDA would be barred from advising the agency under draft guidelines issued last week.

The guidelines also would limit the participation of experts if they had held a generally disqualifying financial interest within the preceding year. The FDA has provided a flowchart for agency employees to follow when seeking potential advisers.

The new policy would affect a "significant number" of present board members, FDA Acting Commissioner Randall W. Lutter told The New York Times. Last month, former FDA Commissioner Lester Crawford pleaded guilty to lying about owning stock in FDA-regulated companies. He received three years' supervised probation and was fined about $90,000.



Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles